tiprankstipranks
Trending News
More News >
Biocure Technology Inc (TSE:CURE.X)
:CURE.X
Canadian Market

Biocure Technology Inc (CURE.X) Income Statement

Compare
4 Followers

Biocure Technology Inc Income Statement

Last quarter (Q3 2024), Biocure Technology Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Biocure Technology Inc's net income was $-8.97K. See Biocure Technology Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ 76.88K$ 54.90K$ 44.81K
EBITDA
$ -1.49M$ -403.40K$ -1.80M$ -2.78M$ -4.61M
Operating Income
$ -1.08M$ -696.24K$ -3.90M$ -2.97M$ -4.60M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -1.81M$ -1.45M$ -1.13M$ -2.95M$ -4.74M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Biocure Technology Inc Earnings and Revenue History